Work

Treatment With Quizartinib (AC220) Enables a High Rate of Patients With Relapsed or Refractory FLT3-ITD(+) Acute Myeloid Leukemia to be Bridged to HSCT

Year: 2014

Type: article

Authors: Giovanni Martinelli, Mark J. Levis, Alexander E. Perl, Hervé Dombret, Björn Steffen, Philippe Rousselot, Elihu H. Estey, Neil P. Shah, Guy Gammon, Denise Trone, Jorge E. Cortés, Aml Progression

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2184994254

FWCI: 0.236

Cites:

Cited by: 2

Related to: 10